Market Movers: Sanofi SA (ADR) (NYSE:SNY), GlaxoSmithKline plc (ADR) (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Amgen (NASDAQ:AMGN), Bayer AG (ADR) (OTCMKTS: BAYRY)

On 23 JUNE Sanofi SA (ADR) (NYSE:SNY) and biopharmaceutical company Merrimack Pharmaceuticals Inc (NASDAQ:MACK) have reached an understanding allowing Merrimack to develop and commercialize monoclonal antibody drug MM-121. Sanofi SA (ADR) (NYSE:SNY) net profit margin is 9.10% and weekly performance is -0.45%. On last trading day company shares ended up $53.50. Analysts mean target price for the company is $57.88. Sanofi SA (ADR) (NYSE:SNY) distance from 50-day simple moving average (SMA50) is 1.57%.

On 24 JUNE GlaxoSmithKline plc (ADR) (NYSE:GSK) reported $0.70 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.72 by $0.02. Analysts expect that GlaxoSmithKline plc will post $3.49 EPS for the current fiscal year. GlaxoSmithKline plc (ADR) (NYSE:GSK) shares fell -0.56% in last trading session and ended the day on $53.42. GSK Gross Margin is 69.60% and its return on assets is 17.30%. GlaxoSmithKline plc (ADR) (NYSE:GSK) quarterly performance is 0.85%.

On 16 JUNE Abbott Laboratories (NYSE:ABT) reported $0.41 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.36 by $0.05. The company had revenue of $5.24 billion for the quarter, compared to the consensus estimate of $5.29 billion. During the same quarter last year, the company posted $0.42 earnings per share. Abbott Laboratories’s revenue was down 2.5% compared to the same quarter last year. On average, analysts predict that Abbott Laboratories will post $2.20 earnings per share for the current fiscal year. Abbott Laboratories (NYSE:ABT) shares moved up 0.62% in last trading session and was closed at $40.70, while trading in range of $40.44 – $40.98. Abbott Laboratories (NYSE:ABT) year to date (YTD) performance is 7.42%.

On 24 JUNE Amgen, Inc. (NASDAQ:AMGN) reported $1.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.94 by $0.07. The company had revenue of $4.52 billion for the quarter, compared to the consensus estimate of $4.76 billion. During the same quarter in the previous year, the company posted $1.96 earnings per share. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. On average, analysts predict that Amgen will post $8.09 earnings per share for the current fiscal year. Amgen, Inc. (NASDAQ:AMGN) ended the last trading day at $119.42. Company weekly volatility is calculated as 1.77% and price to cash ratio as 4.57. Amgen, Inc. (NASDAQ:AMGN) showed a positive weekly performance of 1.64%.

Bayer AG (ADR) (OTCMKTS: BAYRY) issued two hybrid bonds with a total volume of EUR 3.25 billion. This issuance is the first step in the refinancing of the USD 14.2 billion bridge loan arranged to finance Bayer AG (ADR) (OTCMKTS:BAYRY) ‘s acquisition of the consumer care business of Merck & Co., Inc., Whitehouse Station, New Jersey, United States. Bayer AG (ADR) (OTCMKTS: BAYRY) on last trading day company shares ended up $142.66.